Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Functional IOL Implantation in Patients With Epiretinal Membrane

NCT: NCT06719739 · RECRUITING

NCT IDNCT06719739
StatusRECRUITING
Start Date2024-09-21
Completion2026-09-21

Brief Summary

We have designed this prospective study to evaluate macular involvement and epiretinal membrane (ERM) grading by OCT in eyes with ERM and to compare clinical outcomes after implantation of Enhance IOL with standard monofocal IOL in eyes with ERM grading preoperatively, aiming to find out whether functional IOL is benefit for patients with ERM.

Frequently Asked Questions

What is Functional IOL Implantation in Patients With Epiretinal Membrane?

Functional IOL Implantation in Patients With Epiretinal Membrane is a clinical trial registered under NCT06719739. Current status: RECRUITING.

What is the status of NCT06719739?

The current status of NCT06719739 (Functional IOL Implantation in Patients With Epiretinal Membrane) is: RECRUITING.

When did Functional IOL Implantation in Patients With Epiretinal Membrane start?

Functional IOL Implantation in Patients With Epiretinal Membrane started on 2024-09-21.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑